Credit Suisse Sees Solid Q4 For Amgen
January 28, 2015 at 09:14 AM EST
In a report published Wednesday, Credit Suisse analyst Ravi Mehrotra reiterated a Neutral rating and $180.00 price target on Amgen, Inc. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.